𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacological treatment of Parkinson’s disease: life beyond dopamine D2/D3 receptors?

✍ Scribed by G. Linazasoro; N. Van Blercom; L. Ugedo; J. A. Ruiz Ortega


Publisher
Springer
Year
2008
Tongue
English
Weight
156 KB
Volume
115
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Dopamine D2 receptor TaqI A polymorphism
✍ Mario Zappia; Grazia Annesi; Aldo Quattrone 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 9 KB

We read with interest the article by Grevle and colleagues, 1 reporting in Norway an association between the variant allele A1 of the TaqI A restriction fragment length polymorphism (RFLP) located in the dopamine D2 receptor (DRD2) gene and Parkinson's disease (PD). Similar findings have been report

Insular dopamine D2 receptors and novelt
✍ Valtteri Kaasinen; Sargo Aalto; Kjell Någren; Juha O. Rinne 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract Novelty seeking is a temperament trait characterized by impulsiveness and exploratory behavior. Dopamine has been suggested to be the primary neurotransmitter modulator of novelty seeking, and in young healthy subjects, a correlation between increased novelty seeking and decreased insul

Dopamine D2 receptor TaqIA and TaqIB pol
✍ Eng-King Tan; Yanni Tan; Anthea Chai; Christopher Tan; Hui Shen; Sau-Ying Lum; S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

## Abstract In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significa